Derived from Current Agreements, our editors have selected notable big pharma deals from the life sciences in recent weeks – our Featured deals. Subscribe to our weekly newsletter to be updated on new featured deals and much more.
For comprehensive access to all life science deals as they are announced:
Deal Monitor - part of Current Partnering Insight, Deal Monitor allows you to track recent deals by industry sector, therapy area, technology type and stage of development - access now
Current Agreements - search over 40,000 deals to find benchmarks, monitor target company deal structures, identify companies active in your area(s) of interest, and much more - access now
Featured big pharma deals
All big pharma deals: Deal Monitor | Current Agreements
Pfizer creates breaking news with Allergan purchase
November 23, 2015 : Allergan, big pharma, merger, Pfizer
US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history. more »
When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership
August 10, 2015 : big biotech, big pharma, biotech, partnering, pharma
An interview with Richard Brudnick, Senior VP, Corporate Development, Biogen
De-risking has evolved from literature searches to the cultivation of many wide-ranging relationships throughout the life sciences strata, according to Richard Brudnick, Senior VP, Corporate Development at Biogen. In a recent interview, Brudnick outlined key strategies to accessing innovation and “de-risking” risk through collaboration. more »
Boehringer Ingelheim acquires Pharmaxis’ anti-inflammatory candidate
May 18, 2015 : Boehringer Ingelheim, Pharmaxis
Boehringer Ingelheim exercises option and acquires global ownership of Pharmaxis’ investigational anti-inflammatory drug candidate PXS4728A, including associated intellectual property rights. more »
Endo International acquires Par Pharmaceutical
May 18, 2015 : acquisition, Endo, par
Endo International and Par Pharmaceutical Holdings have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. more »
Transition Therapeutics announced its wholly-owned subsidiary, Transition Therapeutics Ireland Limited, has exclusively licensed worldwide rights to a novel small molecule drug candidate (“TT701”) from Eli Lilly and Company. more »
EMD Serono has begun co-promoting Pfizer’s anaplastic lymphoma kinase (ALK) inhibitor XALKORI (crizotinib) as part of its global strategic alliance with Pfizer. more »
Pfizer in collaboration agreement for lupus study
May 5, 2015 : 23andMe, Pfizer
23andMe announced the launch of the Lupus Research Study in collaboration with Pfizer. more »
Bayer and Isis in ISIS-FXIRx licensing pact
May 5, 2015 : Bayer, big pharma, partnering
Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals on ISIS-FXIRx more »
Roche and 4D Molecular partner for AAV vectors
April 30, 2015 : big pharma, partnering, Roche
4D Molecular Therapeutics announced a collaboration and license agreement with Roche to discover and develop optimized next-generation AAV vectors more »
Celgene acquires Quanticel Pharmaceuticals
April 28, 2015 : big biotech, big pharma, Celgene, M&A
Celgene and Quanticel Pharmaceuticals announced a definitive share purchase agreement under which Celgene will acquire Quanticel more »
Derived from Current Agreements, more featured partnering deals by category:
Big biotech
When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership
August 10, 2015
Morphosys acquires Lanthio Pharma
May 7, 2015
Alexion to buy Synageva Biopharma
May 5, 2015
Pharma
Pfizer creates breaking news with Allergan purchase
November 23, 2015
When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership
August 10, 2015
Biotech
When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership
August 10, 2015
Veracyte banks $40 million private placement
April 28, 2015
Diagnostics
Roche acquires Signature Diagnostics for access to translational oncology and genomics
February 12, 2015
Personalis gains $33 million series C
January 14, 2015
Medical device
Mallinckrodt acquires Ikaria for $2.3bn
March 5, 2015
Drug delivery
Sanofi Pasteur and VBI Vaccines in formulation pact
April 9, 2015
